/Companies

Molecule AI

24 known investors

Find your way into Molecule AI

Sign up to see every warm intro you have to Molecule AI

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Molecule AI team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs. It also features labs such as an autonomous AI agent for peptide drug discovery.

Founders & leadership

PKPaul Kohlhaas
Paul KohlhaasFounderFounder at Molecule
NS
Neeta SingalFounder
SS
Saurabh SingalFounder
SS
Saurabh Singal Neeta SingalFounder
TG
Tyler GolatoFounder
VWVincent Weisser
Vincent WeisserFounderExecutive Officer, Director at Prime Intellect

Investors · 24

Shine Capitallisted by Shine CapitalNew York · $1M – $10M

How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 3

Atmos VenturesleadInVenturesSunfish Partners

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

Molecule ONEMolecule.one applies machine learning to chemical synthesis, predicting synthetic routes and supporting chemistry research with an in-house synthetic and analytical laboratory. It serves pharmaceutical and life-science research through its computational and experimental chemistry platform.
MoleculeMolecule is a trade and risk management (ETRM/CTRM) platform for energy and commodity trading operations, automating deal capture, market-data pricing, and calculation of positions, P&L, and risk. It supports 50+ commodities including power, renewables, gas, and crude, and offers reporting, FCM reconciliation across clearing firms, and flexible APIs.
EmoleculeseMolecules operates a digital chemical search platform and procurement service connecting researchers to over 83 million available chemical compounds from a global supplier network. The company serves drug discovery researchers and biopharmaceutical organizations seeking to reduce timelines and improve efficiencies in early-stage compound acquisition and management.
Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
CoingeckoCoinGecko is the world's largest independent cryptocurrency data aggregator, providing comprehensive market data including price, volume, and market capitalization across thousands of cryptoassets. It serves millions of users globally with tools, research, and APIs for cryptocurrency market analysis and insights.

Companies working in the same space as Molecule AI.

Frequently asked questions

What does Molecule AI do?
Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs. It also features labs such as an autonomous AI agent for peptide drug discovery.
Who founded Molecule AI?
Molecule AI was founded by Paul Kohlhaas.
Who are Molecule AI's investors?
Molecule AI's investors include Atria Ventures, Backed, BoxGroup, Compound, Fifty Years, Gaingels, Incrypt Blockchain, Inflection.xyz and 13 more.